Evidence map›Paper›PMID 31839879›Full record

ArticleOncotarget2019

Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a.

Sweta Sikder, Sujata Kumari, Manoj Kumar, Shrinka Sen, Namrata Bora Singhal, Srikumar Chellappan, Mukul Godbole, Pratik Chandrani, Amit Dutt, Kodaganur S Gopinath and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Sweta SikderJawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India.
Sujata KumariJawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India.
Manoj KumarJawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India.
Shrinka SenJawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India.
Namrata Bora SinghalH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Srikumar ChellappanH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Mukul GodboleIntegrated Cancer Genomics Lab, Advanced Centre for Treatment, Research and Education in Cancer, Mumbai, India.
Pratik ChandraniIntegrated Cancer Genomics Lab, Advanced Centre for Treatment, Research and Education in Cancer, Mumbai, India.
Amit DuttIntegrated Cancer Genomics Lab, Advanced Centre for Treatment, Research and Education in Cancer, Mumbai, India.
Kodaganur S GopinathBangalore Institute of Oncology, Bangalore, India.
Tapas K KunduJawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India.
Jawaharlal Nehru Centre for Advanced Scientific Research · INAdvanced Centre for Treatment, Research and Education in Cancer · INKidwai Memorial Institute of Oncology · INMoffitt Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human transcriptional coactivator PC4 has numerous roles to play in the cell. Other than its transcriptional coactivation function, it facilitates chromatin organization, DNA damage repair, viral DNA replication, etc. Although it was found to be an essential protein

Indexed as

matrix metalloproteinasesnon-histone chromatin proteinoncomiRp53 activationtumour suppressor

Identifiers

PMID31839879
PMCPMC6901337
OpenAlexW2996541033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.